Xiangfei Xue

Xiangfei Xue

Auto-generated profile, based on publicly available information

Xiangfei Xue

Department of Clinical Laboratory Medicine, Shanghai Tenth People’s Hospital of Tongji University, Shanghai, China

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 February 2022 in Cell Death Discovery
Verified
Journal Article
Open access
PDF file
XXXiangfei Xue
Xiangfei Xue
XTXiaoting Tian
Xiaoting Tian
CZCongcong Zhang
Congcong Zhang
YMYayou Miao
Yayou Miao
YWYikun Wang
Yikun Wang
XZXiao Zhang
Xiao Zhang
Yes-associated protein (YAP) activation is crucial for tumor formation and development, and its stability is regulated by ubiquitination. ISGylation is a type of ubiquitination like post-translational modification, whereas whether YAP is ISGylated and how ISGylation influences YAP ubiquitination-related function remains uncovered. In addition, YAP can activate glucose metabolism by activating the hexosamine biosynthesis pathway (HBP) and glycolysis, and generate a large number of intermediates to promote tumor proliferation. However, whether YAP stimulates the pentose phosphate pathway (PPP), another tumor-promoting glucose metabolism pathway, and the relationship between this stimulation and ISGylation needs further investigation. Here, we found that YAP was ISGylated and this ISGylation inhibited YAP ubiquitination, proteasome degradation, interaction with-beta-transducin repeat containing E3 ubiquitin-protein ligase (βTrCP) to promote YAP stability. However, ISGylation-induced pro-YAP effects were abolished by YAP K497R (K, lysine; R, arginine) mutation, suggesting K497 could be the major YAP ISGylation site. In addition, YAP ISGylation promoted cell viability, cell-derived xenograft (CDX) and patient-derived xenograft (PDX) tumor formation. YAP ISGylation also increased downstream genes transcription, including one of the key enzymes of PPP, 6-phosphogluconolactonase (6PGL). Mechanistically, YAP promoted 6PGL transcription by simultaneously recruiting SMAD family member 2 (SMAD2) and TEA domain transcription factor 4 (TEAD4) binding to the 6PGL promoter to activate PPP. In clinical lung adenocarcinoma (LUAD) specimens, we found that YAP ISGylation degree was positively associated with 6PGL mRNA level, especially in high glucose LUAD tissues compared to low glucose LUAD tissues. Collectively, this study suggested that YAP ISGylation is critical for maintaining its stability and further activation of PPP. Targeting ISGylated YAP might be a new choice for hyperglycemia cancer treatment.

30 September 2026 in Ferroptosis and Oxidative Stress
Verified
Journal Article
Open access
PDF file
WGWanxin Guo
Wanxin Guo
LQLei Qian
Lei Qian
SGSusu Guo
Susu Guo
SQShiyu Qiu
Shiyu Qiu
XXXiangfei Xue
Xiangfei Xue
JWJiayi Wang
Jiayi Wang
Ferroptosis is an iron-dependent form of regulated cell death driven by the lethal accumulation of lipid peroxides. Accumulating evidence indicates that the extracellular landscape, the acellular functional subset of the tumor microenvironment (TME) comprising the extracellular matrix, soluble metabolites, cytokines, extracellular vesicles (EVs), and physicochemical conditions such as pH and oxygen content, actively determines cellular susceptibility to ferroptosis. Extracellular nutrients, acidic and hypoxic conditions modulate intracellular redox homeostasis, while ferroptosis-related signals are transmitted between cells through EVs, cytokines, and metabolites. Ferroptosis in turn bidirectionally shapes anti-tumor immunity, acting as immunogenic cell death yet also releasing immunosuppressive mediators that impair T cells. This review summarizes the canonical intracellular mechanisms of ferroptosis, highlights the bidirectional crosstalk between cells and the extracellular landscape, and discusses therapeutic strategies targeting this landscape, including reshaping nutrient availability, engineering EV-based delivery systems, and designing microenvironment-responsive nanomaterials. Key limitations of the field and perspectives are also outlined for safe and effective ferroptosis-based anti-tumor therapies.